11:19:40 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-08-27 Kvartalsrapport 2024-Q2
2024-03-22 Årsstämma 2024
2024-03-14 Bokslutskommuniké 2023
2023-08-29 Kvartalsrapport 2023-Q2
2023-03-27 Ordinarie utdelning FARON 0.00 EUR
2023-03-24 Årsstämma 2023
2023-03-03 Bokslutskommuniké 2022
2022-08-25 Kvartalsrapport 2022-Q2
2022-07-07 Extra Bolagsstämma 2022
2022-04-25 Ordinarie utdelning FARON 0.00 EUR
2022-04-22 Årsstämma 2022
2022-03-25 Bokslutskommuniké 2021
2021-08-26 Kvartalsrapport 2021-Q2
2021-04-26 Ordinarie utdelning FARON 0.00 EUR
2021-04-23 Årsstämma 2021
2021-03-25 Bokslutskommuniké 2020
2020-05-14 Ordinarie utdelning FARON 0.00 EUR
2020-05-13 Årsstämma 2020
2020-03-20 Bokslutskommuniké 2019

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriBioteknik
Faron Pharmaceuticals är verksamt inom medicinteknik. Bolaget bedriver forskning och utveckling av terapeutiska lösningar som används för behandling av immuna sjukdomar och diverse organskador. Störst verksamhet återfinns inom Nordamerika samt Europa, med sjukhus och forskningsinstitut som dominerande kundbas. Utöver huvudverksamheten erbjuds diverse mervärdestjänster. Huvudkontoret ligger i Turku.
2023-02-01 16:45:00

TR-1: Standard form for notification of major holdings

NOTIFICATION OF
MAJOR HOLDINGS
(to
be sent to the
relevant issuer
and
to the FCA in
Microsoft Word
format
if possible) i

1a. Identity of Faron Pharmaceuticals
the issuer or the Ltd
underlying issuer
of existing
shares
to which voting
rights are
attached
ii:
1b. Please
indicate if the
issuer is
a non-UK issuer
(please mark with
an
"X" if
appropriate)
Non-UK issuer X
2. Reason for the
notification
(please mark the
appropriate box
or
boxes with an
"X")
An acquisition or
disposal of
voting
rights
An acquisition or
disposal of
financial
instruments
An event changing X
the breakdown of
voting rights
Other (please X
specify) iii:
(Decrease of
holding due to
issuance
of new shares)
3. Details of
person subject to
the
notification
obligation iv
Name Tom-Erik Lind
City and country
of registered
office (if
applicable)
4. Full name of
shareholder(s)
(if
different from
3.) v
Name
City and country
of registered
office (if
applicable)
5. Date on which 27.01.2023
the threshold was
crossed or
reached vi:
6. Date on which 30.01.2023
issuer notified
(DD/MM/YYYY):
7. Total
positions of
person(s)
subject to the
notification
obligation
% of voting % of voting Total of both Total
rights rights in % (8.A + number of
attached to through 8.B) voting
shares financial rights
(total instruments held in
of 8. A) (total of issuer
8.B 1 + 8.B (8.A +
2) 8.B) vii
Resulting 5.77% 5.77% 3,666,647
situation on the
date on
which threshold
was crossed or
reached
Position of 6.13% 6.13%
previous
notification
(if

applicable)

8. Notified
details of the
resulting
situation on
the date on
which the
threshold was
crossed or
reached viii
A: Voting
rights
attached to
shares
Class/type of Number of % of
shares voting voting
rights ix rights
ISIN code (if
possible)
Direct Indirect Direct Indirect

(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
FI4000153309 3,666,647 5.77%

SUBTOTAL 8. A 3,666,647 5.77%

B 1: Financial
Instruments
according to
DTR5.3.1R (1)
(a)
Type of Expiration Exercise/ Number of % of
financial date x Conversion voting voting
instrument Period xi rights rights
that may
be
acquired
if the
instrument
is

exercised/c
onverted.

SUBTOTAL
8. B 1

B 2: Financial
Instruments
with similar
economic
effect
according to
DTR5.3.1R (1)
(b)
Type of Expiration Exercise/ Physical Number of voting % of
financial date x Conversion or cash rights voting
instrument Period xi rights
Settlement
xii

SUBTOTAL
8.B.2

9. Information
in relation to
the person
subject to the
notification
obligation
(please mark
the

applicable box
with an "X")
Person subject X
to the
notification
obligation is
not controlled
by any natural
person or
legal entity
and does not
control any
other
undertaking(s)
holding
directly or
indirectly an
interest in
the
(underlying)
issuer xiii
Full chain of
controlled
undertakings
through which
the voting
rights and/or
the
financial
instruments
are
effectively
held starting
with the
ultimate
controlling
natural person
or legal
entity (please
add additional
rows as
necessary) xiv
Name xv % of voting rights if it equals or is % of voting Total of
higher than the notifiable threshold rights both if it
through equals or is
financial higher than
instruments the
if it notifiable
equals or threshold
is higher
than the
notifiable
threshold
Tom-Erik Lind 5.77% 5.77%

10. In case of
proxy voting,
please
identify:
Name of the
proxy holder
The number and
% of voting
rights held
The date until
which the
voting rights
will be held

11. Additional
information
xvi
Faron share
issue per
27.01.2023

+-------------------+-----------------+
|Place of completion|Bangkok, Thailand|
+-------------------+-----------------+
|Date of completion |27.01.2023 |
+-------------------+-----------------+